Related Experiment Video
Updated: Nov 20, 2025
Author Spotlight: Enhancing Graft Viability Assessment Through Quantitative Metrics and Innovative Reservoir Systems
Published on: August 2, 2024
PET Assessment of Cardiac Allograft Vasculopathy
Sharon Chih1, Christiane C Wiefels2, Rob S B Beanlands2
1Heart Failure and Transplantation, University of Ottawa Heart Institute, Ottawa, Ontario, Canada.
Insights
Cardiac allograft vasculopathy (CAV) after heart transplant is challenging to image. Cardiac PET offers accurate diagnosis and risk stratification for CAV patients, but further studies are needed.
Area of Science:
- Cardiology
- Immunology
- Medical Imaging
Background:
- Heart transplantation is a vital treatment for end-stage heart disease.
- Cardiac allograft vasculopathy (CAV) is a common and serious complication post-transplant, leading to graft failure and mortality.
- Traditional imaging methods struggle with CAV due to its diffuse vascular involvement.
Purpose of the Study:
- To evaluate the role of cardiac positron emission tomography (PET) in diagnosing and assessing cardiac allograft vasculopathy (CAV).
- To highlight the utility of PET-derived myocardial blood flow and flow reserve in CAV evaluation and patient risk stratification.
Main Methods:
- Review of current evidence and guidelines recommending cardiac PET for CAV surveillance.
- Analysis of diagnostic accuracy and prognostic value of PET-based myocardial perfusion quantification.
Main Results:
- Cardiac PET demonstrates high accuracy in diagnosing CAV.
- PET myocardial blood flow and flow reserve measurements are valuable for risk stratification in heart transplant recipients.
- PET imaging effectively addresses the limitations of other noninvasive techniques in detecting diffuse CAV.
Conclusions:
- Cardiac PET is a recommended and accurate imaging modality for CAV evaluation.
- PET offers significant utility for risk stratification in post-heart transplant patients with CAV.
- Further multicenter prospective studies are required to optimize PET parameters and establish diagnostic/prognostic thresholds for CAV.
Abstract:
Heart transplantation is an effective and life-saving therapy for patients with end-stage heart disease. Cardiac allograft vasculopathy (CAV) is a frequent complication after heart transplantation and a leading cause of graft failure and death. The diffuse involvement of the coronary macro- and microvasculature in CAV poses significant challenges for noninvasive imaging surveillance techniques that depend on regional differences in myocardial perfusion or contractility to detect abnormalities. Recent imaging and transplantation guidelines recommend cardiac PET for CAV evaluation. Current evidence demonstrates high diagnostic accuracy of PET myocardial blood flow and myocardial flow reserve quantification for CAV as well as utility for post-transplant patient risk stratification. Multicenter prospective studies are needed to determine optimal PET measures and to define thresholds for diagnostic and prognostic assessment of CAV.
